Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
179.87
+5.08 (2.91%)
At close: Jun 3, 2026, 4:00 PM EDT
179.87
0.00 (0.00%)
After-hours: Jun 3, 2026, 5:15 PM EDT
CRL Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 25, 2021 |
Cash & Equivalents | 191.83 | 213.77 | 194.61 | 276.77 | 233.91 | 241.21 |
Cash & Short-Term Investments | 191.83 | 213.77 | 194.61 | 276.77 | 233.91 | 241.21 |
Cash Growth | -16.36% | 9.85% | -29.69% | 18.32% | -3.03% | 5.60% |
Accounts Receivable | 700.25 | 708.86 | 720.92 | 780.38 | 752.39 | 642.88 |
Inventory | 359.72 | 299.1 | 278.54 | 380.26 | 255.81 | 199.15 |
Other Current Assets | 237 | 225.32 | 209.01 | 171.26 | 196.92 | 190.85 |
Total Current Assets | 1,489 | 1,447 | 1,403 | 1,609 | 1,439 | 1,274 |
Net Property, Plant & Equipment | 1,828 | 2,017 | 2,017 | 2,034 | 1,857 | 1,584 |
Other Intangible Assets | 248.99 | 340 | 723.4 | 864.05 | 955.28 | 1,061 |
Goodwill | 3,040 | 2,764 | 2,847 | 3,095 | 2,850 | 2,712 |
Long-Term Investments | 209.72 | 206.97 | 218.35 | 243.81 | 311.6 | 201.35 |
Other Long-Term Assets | 914.76 | 360.52 | 320.41 | 349.66 | 189.54 | 191.76 |
Total Assets | 7,730 | 7,135 | 7,528 | 8,195 | 7,603 | 7,024 |
Accounts Payable | 133.95 | 148.8 | 140.34 | 168.94 | 205.92 | 198.13 |
Accrued Expenses | 539.29 | 538.94 | 411.43 | 441.12 | 416.84 | 474.92 |
Unearned Revenue | 194.33 | 210.42 | 248.32 | 241.82 | 264.26 | 219.7 |
Other Current Liabilities | 226.14 | 222.16 | 194.01 | 203.21 | 204.58 | 140.44 |
Total Current Liabilities | 1,094 | 1,120 | 994.1 | 1,055 | 1,092 | 1,033 |
Long-Term Debt | 2,663 | 2,136 | 2,240 | 2,647 | 2,708 | 2,664 |
Long-Term Leases | 393.11 | 434.05 | 483.79 | 419.23 | 389.75 | 252.97 |
Other Long-Term Liabilities | 592.05 | 233.51 | 302.17 | 414.54 | 390.4 | 482.58 |
Total Long-Term Liabilities | 3,648 | 2,804 | 3,026 | 3,481 | 3,488 | 3,399 |
Total Liabilities | 4,742 | 3,924 | 4,020 | 4,536 | 4,579 | 4,432 |
Common Stock | 0.49 | 0.49 | 0.51 | 0.51 | 0.51 | 0.51 |
Treasury Stock | -209.99 | - | - | - | - | - |
Additional Paid-in Capital | 1,967 | 1,947 | 1,966 | 1,906 | 1,805 | 1,718 |
Accumulated Other Comprehensive Income | -191.04 | -171.78 | -317.35 | -196.43 | -262.06 | -164.74 |
Retained Earnings | 1,374 | 1,389 | 1,812 | 1,887 | 1,433 | 980.75 |
Total Common Shareholders' Equity | 2,941 | 3,165 | 3,462 | 3,597 | 2,976 | 2,535 |
Minority Interest | 5.82 | 5.3 | 5.45 | 5.39 | 4.79 | 4.16 |
Shareholders' Equity | 2,946 | 3,170 | 3,467 | 3,602 | 2,981 | 2,539 |
Total Liabilities & Equity | 4,784 | 7,135 | 7,528 | 4,593 | 4,622 | 4,485 |
Total Debt | 3,056 | 2,570 | 2,724 | 3,066 | 3,097 | 2,917 |
Net Cash (Debt) | -2,864 | -2,357 | -2,529 | -2,790 | -2,863 | -2,675 |
Net Cash Per Share | -59.47 | -47.49 | -49.22 | -54.49 | -55.81 | -52.02 |
Book Value | 2,941 | 3,165 | 3,462 | 3,597 | 2,976 | 2,535 |
Book Value Per Share | 61.05 | 63.78 | 67.36 | 70.26 | 58.02 | 49.29 |
Tangible Book Value | -348.43 | 60.38 | -108.51 | -362.21 | -828.89 | -1,238 |
Tangible Book Value Per Share | -7.23 | 1.22 | -2.11 | -7.08 | -16.16 | -24.08 |